The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease

Increasing evidence suggests that abnormally hyperphosphorylated tau plays a vital role in the pathogenesis of Alzheimer's disease (AD). Mitochondrial dysfunction also has a recognized role in the pathophysiology of AD. In recent years, mitochondrial dysfunction has been strongly associated with tau pathology in AD. Overexpression of hyperphosphorylated and aggregated tau appears to damage the axonal transport, leading to abnormal mitochondrial distribution. In addition, pathological tau impairs mitochondrial dynamics by regulating mitochondrial fission/fusion proteins, and further causes mitochondrial dysfunction and neuronal damage. Moreover, mitochondrial dysfunction is also involved in promoting tau pathology in AD. In this article, we evaluate the relationship between phosphorylated tau and mitochondrial dysfunction in AD.

[1]  S. Cajal,et al.  DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis , 2017, Molecular Neurobiology.

[2]  P. Reddy,et al.  Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease. , 2016, Human molecular genetics.

[3]  O. Shirihai,et al.  Mitochondrial morphology transitions and functions: implications for retrograde signaling? , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[4]  E. Mandelkow,et al.  Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.

[5]  Y. Toyoshima,et al.  Regulation of Mitochondrial Transport and Inter-Microtubule Spacing by Tau Phosphorylation at the Sites Hyperphosphorylated in Alzheimer's Disease , 2012, The Journal of Neuroscience.

[6]  J. Götz,et al.  Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity , 2011, Alzheimer's Research & Therapy.

[7]  G. Hart,et al.  O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Benedikt Westermann,et al.  Molecular Machinery of Mitochondrial Fusion and Fission* , 2008, Journal of Biological Chemistry.

[9]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[10]  Q. Tian,et al.  Overexpression of tau proteins antagonizes amyloid-beta-potentiated apoptosis through mitochondria-caspase-3 pathway in N2a cells. , 2010, Journal of Alzheimer's disease : JAD.

[11]  B. Hyman,et al.  Soluble forms of tau are toxic in Alzheimer’s disease , 2012, Translational neuroscience.

[12]  B. Westermann.  Bioenergetic role of mitochondrial fusion and fission. , 2012, Biochimica et biophysica acta.

[13]  B. Su,et al.  Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases , 2017, Antioxidants.

[14]  George Perry,et al.  Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease , 2009, The Journal of Neuroscience.

[15]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[17]  G. Hart,et al.  The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine* , 1996, The Journal of Biological Chemistry.

[18]  Heng Du,et al.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[19]  Xiongwei Zhu,et al.  A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[20]  Eugenia Trushina,et al.  Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease , 2017, Journal of Alzheimer's disease : JAD.

[21]  R. Ravid,et al.  Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.

[22]  Huaxi Xu,et al.  Phosphorylation of tau antagonizes apoptosis by stabilizing β-catenin, a mechanism involved in Alzheimer's neurodegeneration , 2007, Proceedings of the National Academy of Sciences.

[23]  W. Markesbery,et al.  Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. , 2005, Journal of Alzheimer's disease : JAD.

[24]  R. Neve,et al.  The microtubule binding domain of tau protein , 1989, Neuron.

[25]  K. Ye,et al.  Human wild-type full-length tau accumulation disrupts mitochondrial dynamics and the functions via increasing mitofusins , 2016, Scientific Reports.

[26]  P. Reddy,et al.  Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. , 2012, Human molecular genetics.

[27]  E. Mandelkow,et al.  Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses , 2003, Neurobiology of Aging.

[28]  J. Kuret,et al.  Evaluating triggers and enhancers of tau fibrillization , 2005, Microscopy research and technique.

[29]  Qian Cai,et al.  Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[30]  George Perry,et al.  Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. , 2010, Biochimica et biophysica acta.

[31]  L. Tan,et al.  Axonal Transport Defects in Alzheimer’s Disease , 2014, Molecular Neurobiology.

[32]  Xinglong Wang,et al.  Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. , 2014, Biochimica et biophysica acta.

[33]  S. Lovestone,et al.  GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila , 2004, Molecular Psychiatry.

[34]  J. Brion,et al.  Glycogen synthase kinase-3β and the p25 activator of cyclin dependent kinase 5 increase pausing of mitochondria in neurons , 2010, Neuroscience.

[35]  A. Andreadis,et al.  Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal Phosphotransferases , 2011, The Journal of Neuroscience.

[36]  L. Scorrano,et al.  OPA1 requires mitofusin 1 to promote mitochondrial fusion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. Marra,et al.  A peptide containing residues 26-44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator. , 2008, Biochimica et biophysica acta.

[38]  Michael P. Mazanetz,et al.  Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases , 2007, Nature Reviews Drug Discovery.

[39]  P. Reddy,et al.  Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease. , 2012, Human molecular genetics.

[40]  L. Amos,et al.  Microtubule structure and its stabilisation. , 2004, Organic & biomolecular chemistry.

[41]  C. Masters,et al.  Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau , 2007, PloS one.

[42]  Xiongwei Zhu,et al.  Mitochondrial Dynamics in Alzheimer’s Disease , 2010, Drugs & aging.

[43]  J. Götz,et al.  Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease* , 2009, The Journal of Biological Chemistry.

[44]  Lin Liu,et al.  Low temperature deformation behavior of an electromagnetically bulged 5052 aluminum alloy , 2016, Scientific Reports.

[45]  S. Patil,et al.  Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons , 2005, Neuroscience Letters.

[46]  Ildefonso Rodríguez-Leyva,et al.  Oxidative Stress Modifies the Levels and Phosphorylation State of Tau Protein in Human Fibroblasts , 2017, Front. Neurosci..

[47]  Xiaomin Song,et al.  Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice , 2009, Proceedings of the National Academy of Sciences.

[48]  J. McCaffery,et al.  Mitochondrial Fusion Protects against Neurodegeneration in the Cerebellum , 2007, Cell.

[49]  E. Hirsch,et al.  Annonacin, a Natural Mitochondrial Complex I Inhibitor, Causes Tau Pathology in Cultured Neurons , 2007, The Journal of Neuroscience.

[50]  V. Skulachev,et al.  Mitochondrial filaments and clusters as intracellular power-transmitting cables. , 2001, Trends in biochemical sciences.

[51]  Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer’s disease , 2014, Neuroscience Bulletin.

[52]  J. Götz,et al.  March separate, strike together--role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease. , 2014, Biochimica et biophysica acta.

[53]  Wendy Noble,et al.  Tau phosphorylation affects its axonal transport and degradation , 2013, Neurobiology of Aging.

[54]  A. M. van der Bliek,et al.  Mitochondrial Fission, Fusion, and Stress , 2012, Science.

[55]  S Lovestone,et al.  GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila , 2004, Molecular Psychiatry.

[56]  M. Pérez,et al.  Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease , 2015, Oxidative medicine and cellular longevity.

[57]  A. Peters,et al.  Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain. , 2011, The American journal of pathology.

[58]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[59]  Jürgen Götz,et al.  Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.

[60]  Kai Zhang,et al.  Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport , 2010, Science.

[61]  Y. Ihara,et al.  One of the antigenic determinants of paired helical filaments is related to tau protein. , 1986, Journal of biochemistry.

[62]  M. Smith,et al.  Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[63]  D. Chan.  Mitochondria: Dynamic Organelles in Disease, Aging, and Development , 2006, Cell.

[64]  M. Pérez,et al.  Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer’s Disease , 2018, Molecular Neurobiology.

[65]  E. Suzuki,et al.  Loss of Axonal Mitochondria Promotes Tau-Mediated Neurodegeneration and Alzheimer's Disease–Related Tau Phosphorylation Via PAR-1 , 2012, PLoS genetics.

[66]  Xiongwei Zhu,et al.  Abnormal mitochondrial dynamics and neurodegenerative diseases. , 2010, Biochimica et biophysica acta.

[67]  R. Rizzuto,et al.  Mitochondrial dynamics and Ca2+ signaling. , 2006, Biochimica et biophysica acta.

[68]  M. Hasegawa.  [Phosphorylation in tau protein]. , 1993, Seikagaku. The Journal of Japanese Biochemical Society.

[69]  Hyoung-Gon Lee,et al.  Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells , 2010, Neuroscience Letters.

[70]  Xiongwei Zhu,et al.  Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer's Disease , 2013, Oxidative medicine and cellular longevity.

[71]  A. Frankfurter,et al.  The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.

[72]  R. Hamilton,et al.  Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.

[73]  D. Chan,et al.  Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases , 2009, Human molecular genetics.